Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

cosette pharmaceuticals, inc. - betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - betamethasone valerate 1.2 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced hpa axis suppression and cushing's syndrome than mature patients because of a larger skin surface area to body weight ratio. hypothalamic-pituitary-adrenal (hpa) axis suppression, cushing's syndrome, and intracranial hypertension have been reported in children receiving topical corticosteroids. manifestations of adrenal suppression in children include linear growth retardation, delayed weight gain, low plasma cortisol levels, and absence of response to acth stimulation. manifestations of intracranial hypertension include bulging fontanelles, headaches, and bilateral papilledema. administration of topic

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

actavis pharma, inc. - betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - betamethasone valerate 1.2 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Καναδάς - Αγγλικά - Health Canada

dominion pharmacal - betamethasone (betamethasone sodium phosphate); gentamicin (gentamicin sulfate) - liquid - 1mg; 3mg - betamethasone (betamethasone sodium phosphate) 1mg; gentamicin (gentamicin sulfate) 3mg - antibacterials

Αρμενία - Αγγλικά - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

krka d.d. - betamethasone (betamethasone dipropionate), betamethasone (betamethasone sodium phosphate) - suspension for injection - 5mg/ml+ 2mg/ml

Μαλαισία - Αγγλικά - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

y.s.p. industries (m) sdn bhd - betamethasone dipropionate; betamethasone sodium phosphate -

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - betamethasone sodium phosphate - ear/eye/nose drops solution - 1mg/1ml

Μαλαισία - Αγγλικά - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

the zyfas medical co., - betamethasone sodium phosphate; betamethasone dipropionate -

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

focus pharmaceuticals ltd - betamethasone sodium phosphate - eye ointment - 1mg/1gram

Μαλαισία - Αγγλικά - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

y.s.p. industries (m) sdn bhd - betamethasone sodium phosphate; betamethasone dipropionate -

Κένυα - Αγγλικά - Pharmacy and Poisons Board

abacus pharma (a) ltd. abacus complex abacus lane off baba dogo road - betamethasone sodium phosphate eye /ear & nose… - ear/eye/nasal drops, solution - 0.1% w/v betamethasone sodium phosphate - ophthalmological and otological preparation: